BrainAurora to Raise HK$515 Million via Discounted Share Placing and Top-Up Subscription

BrainAurora Medical Technology Limited ( (HK:6681) ) just unveiled an update.

BrainAurora Medical Technology Limited has entered into a placing and top-up subscription agreement involving the sale of existing shares by a selling shareholder and the issuance of an equivalent number of new shares under its general mandate, raising expected gross proceeds of about HK$515.2 million. The transaction, conducted at HK$5.6 per share—representing a discount to recent market prices—will result in the placement of approximately 7.27% of the company’s existing share capital to at least six independent professional and institutional investors, with the subsequent issuance of the same number of new shares to the seller, ultimately leading to a modest dilution to about 6.77% of the enlarged share capital and providing additional capital without requiring separate shareholder approval.

The most recent analyst rating on (HK:6681) stock is a Sell with a HK$6.00 price target. To see the full list of analyst forecasts on BrainAurora Medical Technology Limited stock, see the HK:6681 Stock Forecast page.

More about BrainAurora Medical Technology Limited

BrainAurora Medical Technology Limited is a medical technology company listed on the Hong Kong Stock Exchange and operates in the healthcare sector, focusing on the development and commercialisation of medical technologies and related products and services.

Average Trading Volume: 16,569,636

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$8.15B

For detailed information about 6681 stock, go to TipRanks’ Stock Analysis page.